Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v26-EN Version v4-EN
Language English English
Date Updated 2024-03-14 2023-03-31
Drug Identification Number 02162695 02162695
Brand name CYTOVENE CYTOVENE
Common or Proper name ganciclovir for injection ganciclovir for injection
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients GANCICLOVIR GANCICLOVIR
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 500 mg/vial 500 mg/vial
ATC code J05AB J05AB
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-02-14 2023-02-14
Estimated end date 2024-03-31 2023-04-30
Actual end date 2024-03-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments